About
Simon Glerup is a Danish biotech scientist and company founder associated with Aarhus University research and multiple neurodegeneration-focused startups. Public sources identify him as a founder of Draupnir Bio, Muna Therapeutics, and Teitur Trophics, with roles spanning chief executive and chief scientific leadership. His public profile is centered on neuroscience, neurodegenerative disease biology, and translational drug discovery rather than investment management.
Areas of interest
biotechneuroscienceneurodegenerative diseasesdrug discoverytargeted protein degradationprotein biology